Backlinks
| Referring page | DR | Ref. domains | Linked domains | Anchor and target URL |
|---|---|---|---|---|
|
Ressources – Page 13 – CanCOVID
https://cancovid.ca/fr/ressources/page/13?resource_producer=esn&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=drug-interventions&topic[5]=public-health-implementation&topic[6]=treatments&topic[7]=long-covid&topic[8]=long-term-community-care&topic[9]=infectious-diseases-clinical-care
cancovid.ca
|
58 | 9 | 23 |
Dexamethasone in Patients Hospitalized for COVID-19
https://covid19-sciencetable.ca/sciencebrief/dexamethasone-in-patients-hospitalized-for-covid-19
NOFOLLOW
|
|
Ressources – Page 17 – CanCOVID
https://cancovid.ca/fr/ressources/page/17?resource_producer=esn&search&topic[0]=long-covid&topic[10]=immune-system&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-term-community-care&topic[7]=treatments&topic[8]=public-health-implementation&topic[9]=vaccine
cancovid.ca
|
58 | 9 | 23 |
Dexamethasone in Patients Hospitalized for COVID-19
https://covid19-sciencetable.ca/sciencebrief/dexamethasone-in-patients-hospitalized-for-covid-19
NOFOLLOW
|
|
Ressources – Page 17 – CanCOVID
https://cancovid.ca/fr/ressources/page/17?resource_producer=esn&search&topic[0]=long-covid&topic[10]=immune-system&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-term-community-care&topic[7]=treatments&topic[8]=public-health-implementation&topic[9]=vaccine
cancovid.ca
|
58 | 9 | 23 |
Decrease in Antibodies Against SARS-CoV-2 Over Time and Current Role of Serological Testing
https://covid19-sciencetable.ca/sciencebrief/decrease-in-antibodies-against-sars-cov-2-over-time-and-current-role-of-serological-testing
NOFOLLOW
|
|
Resources – Evidence Synthesis Network
https://esnetwork.ca/resources
esnetwork.ca
|
39 | 2 | 59 |
Science Table
https://covid19-sciencetable.ca/
DOFOLLOW
|
|
Ressources – CanCOVID
https://cancovid.ca/fr/ressources?resource_producer=esn&search&topic[0]=long-covid&topic[10]=infectious-diseases-clinical-care&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=drug-interventions&topic[8]=public-health-implementation&topic[9]=public-health-implementation
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Ressources – CanCOVID
https://cancovid.ca/fr/ressources?resource_producer=esn&search&topic[0]=long-covid&topic[10]=infectious-diseases-clinical-care&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=drug-interventions&topic[8]=public-health-implementation&topic[9]=public-health-implementation
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
Ressources – CanCOVID
https://cancovid.ca/fr/ressources?search&topic[0]=long-covid&topic[1]=infectious-diseases-clinical-care&topic[2]=most-common-signs-symptoms&topic[3]=epidemiology&topic[4]=healthcare-workers&topic[5]=drug-interventions&topic[6]=treatments&topic[7]=practice-guidelines&topic[8]=treatments
cancovid.ca
|
58 | 9 | 23 |
Severe Acute Hepatitis in Children of Unknown Etiology
https://covid19-sciencetable.ca/sciencebrief/severe-acute-hepatitis-in-children-of-unknown-etiology
NOFOLLOW
|
|
Ressources – CanCOVID
https://cancovid.ca/fr/ressources?search&topic[0]=long-covid&topic[1]=infectious-diseases-clinical-care&topic[2]=most-common-signs-symptoms&topic[3]=epidemiology&topic[4]=healthcare-workers&topic[5]=drug-interventions&topic[6]=treatments&topic[7]=practice-guidelines&topic[8]=treatments
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Ressources – CanCOVID
https://cancovid.ca/fr/ressources?search&topic[0]=long-covid&topic[1]=infectious-diseases-clinical-care&topic[2]=most-common-signs-symptoms&topic[3]=epidemiology&topic[4]=healthcare-workers&topic[5]=drug-interventions&topic[6]=treatments&topic[7]=practice-guidelines&topic[8]=treatments
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
Resources – Page 2 – CanCOVID
https://cancovid.ca/resources/page/2?resource_producer=st&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=healthcare-workers&topic[7]=infectious-diseases-clinical-care&topic[8]=treatments&topic[9]=public-health-implementation
cancovid.ca
|
58 | 9 | 23 |
Therapeutic Management of Residents of Long-term Care Homes with COVID-19
https://covid19-sciencetable.ca/sciencebrief/therapeutic-management-of-residents-of-long-term-care-homes-with-covid-19-version-1-0
NOFOLLOW
|
|
Resources – Page 2 – CanCOVID
https://cancovid.ca/resources/page/2?resource_producer=st&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=healthcare-workers&topic[7]=infectious-diseases-clinical-care&topic[8]=treatments&topic[9]=public-health-implementation
cancovid.ca
|
58 | 9 | 23 |
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19
https://covid19-sciencetable.ca/brief-category/infectious-diseases-clinical-care
NOFOLLOW
|
|
Resources – Page 2 – CanCOVID
https://cancovid.ca/resources/page/2?resource_producer=st&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=healthcare-workers&topic[7]=infectious-diseases-clinical-care&topic[8]=treatments&topic[9]=public-health-implementation
cancovid.ca
|
58 | 9 | 23 |
The COVID‑19 Pandemic’s Impact on Long-Term Care Homes: Five Lessons Learned
https://covid19-sciencetable.ca/sciencebrief/the-covid-19-pandemics-impact-on-long-term-care-homes-five-lessons-learned
NOFOLLOW
|
|
Resources – Page 2 – CanCOVID
https://cancovid.ca/resources/page/2?resource_producer=st&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=healthcare-workers&topic[7]=infectious-diseases-clinical-care&topic[8]=treatments&topic[9]=public-health-implementation
cancovid.ca
|
58 | 9 | 23 |
Update on COVID‑19 Projections
https://covid19-sciencetable.ca/sciencebrief/update-on-covid-19-projections-19
NOFOLLOW
|
|
COVID-19 Testing – Evidence and Best Practices – Evidence Synthesis Network
https://esnetwork.ca/briefings/covid-19-testing-evidence-and-best-practices-2
esnetwork.ca
|
39 | 2 | 59 |
Science Table
https://covid19-sciencetable.ca/
DOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=public-prevention&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=drug-interventions&topic[5]=public-health-implementation&topic[6]=treatments&topic[7]=healthcare-workers&topic[8]=healthcare-workers&topic[9]=treatments
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=public-prevention&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=drug-interventions&topic[5]=public-health-implementation&topic[6]=treatments&topic[7]=healthcare-workers&topic[8]=healthcare-workers&topic[9]=treatments
cancovid.ca
|
58 | 9 | 23 |
The COVID‑19 Pandemic’s Impact on Long-Term Care Homes: Five Lessons Learned
https://covid19-sciencetable.ca/sciencebrief/the-covid-19-pandemics-impact-on-long-term-care-homes-five-lessons-learned
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=public-prevention&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=drug-interventions&topic[5]=public-health-implementation&topic[6]=treatments&topic[7]=healthcare-workers&topic[8]=healthcare-workers&topic[9]=treatments
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
Ressources – CanCOVID
https://cancovid.ca/fr/ressources?resource_producer=esn&search&topic[0]=long-covid&topic[10]=vaccine&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=treatments&topic[8]=public-health-implementation&topic[9]=healthcare-workers
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Ressources – CanCOVID
https://cancovid.ca/fr/ressources?resource_producer=esn&search&topic[0]=long-covid&topic[10]=vaccine&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=treatments&topic[8]=public-health-implementation&topic[9]=healthcare-workers
cancovid.ca
|
58 | 9 | 23 |
The COVID‑19 Pandemic’s Impact on Long-Term Care Homes: Five Lessons Learned
https://covid19-sciencetable.ca/sciencebrief/the-covid-19-pandemics-impact-on-long-term-care-homes-five-lessons-learned
NOFOLLOW
|
|
Ressources – CanCOVID
https://cancovid.ca/fr/ressources?resource_producer=esn&search&topic[0]=long-covid&topic[10]=vaccine&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=treatments&topic[8]=public-health-implementation&topic[9]=healthcare-workers
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=long-term-care&topic[11]=public-health-implementation&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-term-community-care&topic[7]=treatments&topic[8]=transmission&topic[9]=long-covid
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=long-term-care&topic[11]=public-health-implementation&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-term-community-care&topic[7]=treatments&topic[8]=transmission&topic[9]=long-covid
cancovid.ca
|
58 | 9 | 23 |
The COVID‑19 Pandemic’s Impact on Long-Term Care Homes: Five Lessons Learned
https://covid19-sciencetable.ca/sciencebrief/the-covid-19-pandemics-impact-on-long-term-care-homes-five-lessons-learned
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=long-term-care&topic[11]=public-health-implementation&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-term-community-care&topic[7]=treatments&topic[8]=transmission&topic[9]=long-covid
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
Resources – Page 16 – CanCOVID
https://cancovid.ca/resources/page/16?resource_producer=st&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=drug-interventions&topic[5]=public-health-implementation&topic[6]=community-prevention-transmission&topic[7]=infectious-diseases-clinical-care&topic[8]=educational-materials
cancovid.ca
|
58 | 9 | 23 |
Dexamethasone in Patients Hospitalized for COVID-19
https://covid19-sciencetable.ca/sciencebrief/dexamethasone-in-patients-hospitalized-for-covid-19
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=esn&search&topic[0]=long-covid&topic[10]=practice-guidelines&topic[11]=vaccines-immunity&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=public-prevention&topic[8]=workplace-regulations&topic[9]=drug-interventions
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=esn&search&topic[0]=long-covid&topic[10]=practice-guidelines&topic[11]=vaccines-immunity&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=public-prevention&topic[8]=workplace-regulations&topic[9]=drug-interventions
cancovid.ca
|
58 | 9 | 23 |
The COVID‑19 Pandemic’s Impact on Long-Term Care Homes: Five Lessons Learned
https://covid19-sciencetable.ca/sciencebrief/the-covid-19-pandemics-impact-on-long-term-care-homes-five-lessons-learned
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=esn&search&topic[0]=long-covid&topic[10]=practice-guidelines&topic[11]=vaccines-immunity&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=public-prevention&topic[8]=workplace-regulations&topic[9]=drug-interventions
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
Ressources – CanCOVID
https://cancovid.ca/fr/ressources?resource_producer=st&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=drug-interventions&topic[4]=long-term-care&topic[5]=community-prevention-transmission
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Ressources – CanCOVID
https://cancovid.ca/fr/ressources?resource_producer=st&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=drug-interventions&topic[4]=long-term-care&topic[5]=community-prevention-transmission
cancovid.ca
|
58 | 9 | 23 |
The COVID‑19 Pandemic’s Impact on Long-Term Care Homes: Five Lessons Learned
https://covid19-sciencetable.ca/sciencebrief/the-covid-19-pandemics-impact-on-long-term-care-homes-five-lessons-learned
NOFOLLOW
|
|
Ressources – CanCOVID
https://cancovid.ca/fr/ressources?resource_producer=st&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=drug-interventions&topic[4]=long-term-care&topic[5]=community-prevention-transmission
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=cochrane&search&topic[0]=long-covid&topic[10]=healthcare-workers&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=treatments&topic[8]=infectious-diseases-clinical-care&topic[9]=long-covid
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=cochrane&search&topic[0]=long-covid&topic[10]=healthcare-workers&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=treatments&topic[8]=infectious-diseases-clinical-care&topic[9]=long-covid
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
Resources – Evidence Synthesis Network
https://esnetwork.ca/resources?organization=mcmaster-rise
esnetwork.ca
|
39 | 2 | 59 |
Science Table
https://covid19-sciencetable.ca/
DOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=esn&search&topic[0]=long-covid&topic[10]=drug-interventions&topic[11]=vaccines-immunity&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=drug-interventions&topic[8]=long-term-care&topic[9]=treatments
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=esn&search&topic[0]=long-covid&topic[10]=drug-interventions&topic[11]=vaccines-immunity&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=drug-interventions&topic[8]=long-term-care&topic[9]=treatments
cancovid.ca
|
58 | 9 | 23 |
The COVID‑19 Pandemic’s Impact on Long-Term Care Homes: Five Lessons Learned
https://covid19-sciencetable.ca/sciencebrief/the-covid-19-pandemics-impact-on-long-term-care-homes-five-lessons-learned
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=esn&search&topic[0]=long-covid&topic[10]=drug-interventions&topic[11]=vaccines-immunity&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-covid&topic[7]=drug-interventions&topic[8]=long-term-care&topic[9]=treatments
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
COVID-19 in Canada
https://www.cemppr.org/research/covid-19-in-canada
cemppr.org
|
— | 0 | 56 |
https://covid19-sciencetable.ca/
https://covid19-sciencetable.ca/
DOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=cochrane&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=drug-interventions&topic[4]=long-term-care&topic[5]=healthcare-workers&topic[6]=public-health-implementation&topic[7]=vulnerable-groups
cancovid.ca
|
58 | 9 | 23 |
Severe Acute Hepatitis in Children of Unknown Etiology
https://covid19-sciencetable.ca/sciencebrief/severe-acute-hepatitis-in-children-of-unknown-etiology
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=cochrane&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=drug-interventions&topic[4]=long-term-care&topic[5]=healthcare-workers&topic[6]=public-health-implementation&topic[7]=vulnerable-groups
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=cochrane&search&topic[0]=long-covid&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=drug-interventions&topic[4]=long-term-care&topic[5]=healthcare-workers&topic[6]=public-health-implementation&topic[7]=vulnerable-groups
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=vaccine&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=drug-interventions&topic[5]=public-health-implementation&topic[6]=transmission&topic[7]=public-prevention&topic[8]=long-term-community-care&topic[9]=public-health-implementation
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=vaccine&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=drug-interventions&topic[5]=public-health-implementation&topic[6]=transmission&topic[7]=public-prevention&topic[8]=long-term-community-care&topic[9]=public-health-implementation
cancovid.ca
|
58 | 9 | 23 |
The COVID‑19 Pandemic’s Impact on Long-Term Care Homes: Five Lessons Learned
https://covid19-sciencetable.ca/sciencebrief/the-covid-19-pandemics-impact-on-long-term-care-homes-five-lessons-learned
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=vaccine&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=drug-interventions&topic[5]=public-health-implementation&topic[6]=transmission&topic[7]=public-prevention&topic[8]=long-term-community-care&topic[9]=public-health-implementation
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=community-prevention-transmission&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=drug-interventions&topic[5]=public-health-implementation&topic[6]=treatments&topic[7]=treatments&topic[8]=long-term-care&topic[9]=practice-guidelines
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=community-prevention-transmission&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=drug-interventions&topic[5]=public-health-implementation&topic[6]=treatments&topic[7]=treatments&topic[8]=long-term-care&topic[9]=practice-guidelines
cancovid.ca
|
58 | 9 | 23 |
The COVID‑19 Pandemic’s Impact on Long-Term Care Homes: Five Lessons Learned
https://covid19-sciencetable.ca/sciencebrief/the-covid-19-pandemics-impact-on-long-term-care-homes-five-lessons-learned
NOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=community-prevention-transmission&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=drug-interventions&topic[5]=public-health-implementation&topic[6]=treatments&topic[7]=treatments&topic[8]=long-term-care&topic[9]=practice-guidelines
cancovid.ca
|
58 | 9 | 23 |
Paxlovid for a Patient on a DOAC
https://covid19-sciencetable.ca/sciencebrief/paxlovid-for-a-patient-on-a-doac
NOFOLLOW
|
|
Resources – Page 17 – CanCOVID
https://cancovid.ca/resources/page/17?resource_producer=esn&search&topic[0]=long-covid&topic[10]=vaccine&topic[11]=vaccines-immunity&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-term-community-care&topic[7]=treatments&topic[8]=public-health-implementation&topic[9]=vaccine
cancovid.ca
|
58 | 9 | 23 |
Dexamethasone in Patients Hospitalized for COVID-19
https://covid19-sciencetable.ca/sciencebrief/dexamethasone-in-patients-hospitalized-for-covid-19
NOFOLLOW
|
|
Resources – Evidence Synthesis Network
https://esnetwork.ca/resources?product-name=ices-report
esnetwork.ca
|
39 | 2 | 59 |
Science Table
https://covid19-sciencetable.ca/
DOFOLLOW
|
|
Resources – Evidence Synthesis Network
https://esnetwork.ca/resources?content-tag=mental-health
esnetwork.ca
|
39 | 2 | 59 |
Science Table
https://covid19-sciencetable.ca/
DOFOLLOW
|
|
Resources – CanCOVID
https://cancovid.ca/resources?resource_producer=st&search&topic[0]=long-covid&topic[10]=long-term-care&topic[11]=long-term-care&topic[1]=treatments&topic[2]=long-term-community-care&topic[3]=treatments&topic[4]=public-prevention&topic[5]=vaccines-immunity&topic[6]=long-term-community-care&topic[7]=treatments&topic[8]=transmission&topic[9]=long-covid
cancovid.ca
|
58 | 9 | 23 |
Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
https://covid19-sciencetable.ca/sciencebrief/nirmatrelvir-ritonavir-paxlovid-what-prescribers-and-pharmacists-need-to-know-3-0
NOFOLLOW
|
Frequently Asked Questions
How many backlinks does covid19-sciencetable.ca have?
The backlinks page for covid19-sciencetable.ca shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on covid19-sciencetable.ca. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to covid19-sciencetable.ca dofollow or nofollow?
Backlinks to covid19-sciencetable.ca include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.